bortezomib,lenalidomide,dexamethasone,daratumumab
janssen,takeda
daratumumab plus rvd improves clinical outcomes in transplant-eligible, newly diagnosed multiple myeloma #ims2022 #mmsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.